Amwell (AMWL) stock price, revenue, and financials
Amwell market cap is $8.3 b, and annual revenue was $148.86 m in FY 2019
$21.34
$8.3 B
AMWL Mkt cap, 08-Feb-2021$62.6 M
Amwell Revenue Q3, 2020Amwell Gross profit (Q3, 2020)20.4 M
Amwell Gross profit margin (Q3, 2020), %32.7%
Amwell Net income (Q3, 2020)-64.6 M
Amwell EBIT (Q3, 2020)-64.3 M
Amwell Cash, 30-Sept-2020956.4 M
Amwell EV7.3 B
Amwell Revenue
Amwell revenue was $148.86 m in FY, 2019 which is a 30.6% year over year increase from the previous period.
Amwell Revenue Breakdown
Amwell revenue breakdown by business segment: 56.2% from Platform subscription, 27.3% from Visits and 16.4% from Other
Amwell Income Statement
Annual
| USD | FY, 2018 | FY, 2019 |
|---|---|---|
Revenue | 114.0m | 148.9m |
Revenue growth, % | 31% | |
Cost of goods sold | 58.6m | 80.0m |
Gross profit | 55.3m | 68.9m |
Gross profit Margin, % | 49% | 46% |
Sales and marketing expense | 31.6m | 47.7m |
R&D expense | 36.3m | 53.9m |
General and administrative expense | 37.2m | 54.2m |
Operating expense total | 110.4m | 155.8m |
Depreciation and amortization | 5.3m | 7.8m |
EBIT | (55.1m) | (94.7m) |
EBIT margin, % | (48%) | (64%) |
Pre tax profit | (52.3m) | (89.2m) |
Income tax expense | (803.0k) | |
Net Income | (52.3m) | (88.4m) |
EPS | (1.3) | (2.1) |
Quarterly
| USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|
Revenue | 33.7m | 35.4m | 34.7m | 53.7m | 68.6m | 62.6m |
Cost of goods sold | 18.6m | 17.4m | 19.1m | 33.0m | 43.8m | 42.1m |
Gross profit | 15.1m | 18.0m | 15.7m | 20.7m | 24.7m | 20.4m |
Gross profit Margin, % | 45% | 51% | 45% | 39% | 36% | 33% |
Sales and marketing expense | 11.2m | 11.5m | 11.3m | 13.9m | 12.3m | 13.8m |
R&D expense | 13.3m | 12.3m | 13.6m | 14.9m | 17.6m | 25.3m |
General and administrative expense | 11.8m | 13.7m | 14.7m | 15.3m | 80.1m | 43.1m |
Operating expense total | 38.2m | 39.4m | 41.4m | 46.4m | 112.6m | 84.7m |
Depreciation and amortization | 1.9m | 1.9m | 1.9m | 2.3m | 2.5m | 2.6m |
EBIT | (23.1m) | (21.4m) | (25.7m) | (25.8m) | (87.8m) | (64.3m) |
EBIT margin, % | (69%) | (60%) | (74%) | (48%) | (128%) | (103%) |
Pre tax profit | (21.5m) | (19.7m) | (24.5m) | (25.8m) | (87.5m) | (64.0m) |
Income tax expense | 370.0k | (392.0k) | (847.0k) | 252.0k | 78.0k | |
Net Income | (21.5m) | (20.1m) | (24.1m) | (24.9m) | (88.2m) | (64.6m) |
EPS | (0.5) | (0.5) | (0.6) | (0.6) | (2.0) | (0.9) |
Amwell Balance Sheet
Annual
| USD | FY, 2018 | FY, 2019 |
|---|---|---|
Cash | 48.0m | 137.7m |
Accounts Receivable | 30.8m | 32.7m |
Prepaid Expenses | 4.8m | 8.9m |
Inventories | 2.5m | 3.1m |
Current Assets | 300.2m | 223.5m |
PP&E | 3.1m | 2.7m |
Goodwill | 127.3m | 193.9m |
Total Assets | 489.3m | 499.9m |
Accounts Payable | 4.2m | 6.5m |
Short-term debt | 6.2m | |
Current Liabilities | 87.8m | 106.6m |
Long-term debt | 7.2m | |
Total Debt | 13.4m | |
Total Liabilities | 118.0m | 124.9m |
Common Stock | 414.0k | 423.0k |
Additional Paid-in Capital | 37.1m | 50.3m |
Retained Earnings | (270.7m) | (357.9m) |
Total Equity | (204.4m) | (280.9m) |
Debt to Equity Ratio | 0 x | |
Debt to Assets Ratio | 0 x | |
Financial Leverage | -2.4 x | -1.8 x |
Quarterly
| USD | Q3, 2020 |
|---|---|
Cash | 956.4m |
Accounts Receivable | 40.0m |
Prepaid Expenses | 8.4m |
Inventories | 7.8m |
Current Assets | 1.1b |
PP&E | 4.4m |
Goodwill | 193.9m |
Total Assets | 1.4b |
Accounts Payable | 7.7m |
Short-term debt | 6.3m |
Current Liabilities | 106.6m |
Long-term debt | 3.1m |
Total Debt | 9.4m |
Total Liabilities | 117.3m |
Common Stock | 2.3m |
Additional Paid-in Capital | 1.8b |
Retained Earnings | (532.0m) |
Total Equity | 1.3b |
Debt to Equity Ratio | 0 x |
Debt to Assets Ratio | 0 x |
Financial Leverage | 1.1 x |
Amwell Cash Flow
Annual
| USD | FY, 2018 | FY, 2019 |
|---|---|---|
Net Income | (53.3m) | (88.4m) |
Depreciation and Amortization | 5.3m | 7.8m |
Accounts Receivable | (19.5m) | 803.0k |
Inventories | 1.6m | (592.0k) |
Accounts Payable | (787.0k) | 1.2m |
Cash From Operating Activities | (74.0m) | (81.9m) |
Purchases of PP&E | (1.9m) | (1.3m) |
Cash From Investing Activities | (245.9m) | 120.0m |
Cash From Financing Activities | 278.2m | 46.6m |
Net Change in Cash | (41.8m) | 84.7m |
Income Taxes Paid | 193.0k |
Quarterly
| USD | Q3, 2019 | Q3, 2020 |
|---|---|---|
Net Income | (65.6m) | (178.0m) |
Depreciation and Amortization | 5.7m | 7.4m |
Accounts Receivable | 11.9m | (8.5m) |
Inventories | (500.0k) | (4.7m) |
Accounts Payable | 13.0k | (135.0k) |
Cash From Operating Activities | (66.6m) | (87.9m) |
Purchases of PP&E | (1.1m) | (3.3m) |
Cash From Investing Activities | 146.5m | (96.7m) |
Cash From Financing Activities | 452.0k | 1.0b |
Net Change in Cash | 80.3m | 818.7m |
Income Taxes Paid | 138.0k |
Amwell Ratios
| USD | FY, 2018 |
|---|---|
Financial Leverage | -2.4 x |
